|
Status |
Public on Mar 13, 2024 |
Title |
Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris |
Organism |
Candidozyma auris |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Candida auris has emerged as a problematic fungal pathogen associated with high morbidity and mortality. Amphotericin B (AmB) is the most effective antifungal used to treat invasive fungal candidiasis, with resistance rarely observed among clinical isolates. However, C. auris possesses extraordinary resistant profiles against all available antifungal drugs, including AmB. In our pursuit of potential solutions, we conducted a screening of a panel of 727 FDA-approved drugs and identified the proton pump inhibitor lansoprazole (LNP) as a potent enhancer of AmB’s activity against C. auris. LNP also potentiates the antifungal activity of AmB against other medically important species of Candida and Cryptococcus. Our investigations into the mechanism of action unveiled that LNP metabolite(s) interact with a crucial target in the mitochondrial respiratory chain (complex III, known as cytochrome bc1). This interaction increases oxidative stress within fungal cells. Our results demonstrated the critical role of an active respiratory function in the antifungal activity of LNP. Most importantly, LNP restored the efficacy of AmB in an immunocompromised mouse model, resulting in a 1.7-log (~98%) CFU reduction in the burden of C. auris in the kidneys. Our findings strongly advocate for a thorough and comprehensive evaluation of LNP as a cytochrome bc1 inhibitor for combating drug-resistant C. auris infections.
|
|
|
Overall design |
Exponential C. auris AR0390 in RPMI 1640 medium were treated with DMSO (control), AmB (0.5 µg/ml), LNP (32 µg/ml), or the combination of AmB/LNP in triplicates for 3 hr at 35 °C.
|
|
|
Contributor(s) |
Salama EA, Elgammal Y, Wijeratne A, Lanman NA, Utturkar SM, Farhangian A, Lie J, Meunier B, Hazbun TR, Seleem MN |
Citation(s) |
38431850 |
|
Submission date |
Sep 26, 2023 |
Last update date |
Apr 11, 2024 |
Contact name |
Tony Hazbun |
E-mail(s) |
[email protected]
|
Phone |
7654968228
|
Organization name |
Purdue University
|
Department |
Borch Medicinal Chemistry and Molecular Pharmacology
|
Lab |
HANS 235
|
Street address |
201 South University Street
|
City |
West Lafayette |
State/province |
Indiana |
ZIP/Postal code |
47906 |
Country |
USA |
|
|
Platforms (1) |
GPL28368 |
Illumina NovaSeq 6000 ([Candida] auris) |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA1021218 |